< Back to previous page
Researcher
Beppe Floris
- Disciplines:Macromolecular and materials chemistry, Laboratory medicine, Morphological sciences
Affiliations
- Translational Cell & Tissue Research (Division)
Member
From12 May 2004 → Today
Projects
1 - 10 of 15
- Quality improvement of diagnostic processes in the oncology fieldFrom18 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular characterization of the tumor microenvironment of breast cancer metastasesFrom11 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- UPTIDER (UZ/KU Leuven Program for post-mortem Tissue Donation to Enhance Research), a unique setting to unravel treatment resistance and disease progression in patients with breast cancer.From1 Oct 2021 → TodayFunding: BOF - projects
- FAT-IBC: Facing adiposity in personalizing treatment of Inflammatory Breast Cancer patients.From1 Jan 2021 → TodayFunding: FWO research project
- Improving immuno-oncology diagnostics by high-dimensional correlation analysis of histopathology and proteomics data in breast cancer samplesFrom4 Sep 2020 → 22 Feb 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- FAT-ILC: Facing Adiposity in personalizing treatment of Invasive Lobular breast Cancer patients.From12 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Integration of complementary, high throughput single-cell omics with spatial resolution.From1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Linking patient adiposity to tumour microenvironment and therapy response in breast cancer: towards tailored treatment strategies in obesityFrom27 Sep 2019 → TodayFunding: Foundations, funds and other with scientific goal, FWO Strategic Basic Research Grant
- Hormone-sensitive breast cancer: Tumor biology, prognostic/predictive biomarkers and specific treatment approachesFrom1 Sep 2019 → TodayFunding: Foundations, funds and other with scientific goal
- Postpartum breast cancer diagnosed during involution: a distinct entity with unique clinicopathological, molecular and immunological features?From1 Jan 2019 → 31 Dec 2021Funding: FWO research project
Publications
1 - 10 of 126
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes(2022)
Authors: Giuseppe Floris, Diether Lambrechts
Number of pages: 13 - Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma(2021)
Authors: Maxim De Schepper, Christine Desmedt, Giuseppe Floris
Pages: 191 - 205Number of pages: 15 - CANCER IN OLDER PERSONS - IMPACT OF AGE ON TUMOR BIOLOGY AND IMMUNE RESPONSE(2021)
Authors: Lieze Berben, Hans Wildiers, Sigrid Hatse, Giuseppe Floris
- Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancer(2021)
Authors: Hanne Vos, Ann Smeets, Giuseppe Floris, Ines Nevelsteen
- Papillary lesions of the breast(2021)
Authors: Giuseppe Floris
Pages: 65 - 84Number of pages: 20 - Towards a better selection of systemic treatment for patients with ER-positive HER2-negative breast cancer: the use of prognostic and predictive markers in early and metastatic setting(2021)
Authors: Laurence Slembrouck, Patrick Neven, Isabelle Vanden Bempt, Giuseppe Floris
- Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group(2021)
Authors: Inne Nauwelaers, Nele Laudus, Giuseppe Floris
Number of pages: 20 - Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer(2021)
Authors: Hanne Vos, Kathleen Lambein, François Richard, Kevin Punie, Hans Wildiers, Lieze Berben, Annouschka Laenen, Giuseppe Floris, Christine Desmedt, Ann Smeets
Number of pages: 5 - Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period(2021)
Authors: Giuseppe Floris, Patrick Neven, Diether Lambrechts, Liesbeth Lenaerts, Frédéric Amant
Number of pages: 15 - Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer(2021)
Authors: Giuseppe Floris
Number of pages: 16